keyword
https://read.qxmd.com/read/38430119/second-line-immunotherapy-in-new-onset-refractory-status-epilepticus
#1
REVIEW
Aurélie Hanin, Eyal Muscal, Lawrence J Hirsch
Several pieces of evidence suggest immune dysregulation could trigger the onset and modulate sequelae of new onset refractory status epilepticus (NORSE), including its subtype with prior fever known as febrile infection-related epilepsy syndrome (FIRES). Consensus-driven recommendations have been established to guide the initiation of first- and second-line immunotherapies in these patients. Here, we review the literature to date on second-line immunotherapy for NORSE/FIRES, presenting results from 28 case reports and series describing the use of anakinra, tocilizumab, or intrathecal dexamethasone in 75 patients with NORSE...
March 2, 2024: Epilepsia
https://read.qxmd.com/read/38168403/longitudinal-program-evaluation-of-an-inter-institutional-mentorship-network-for-pediatric-rheumatology-using-a-quality-improvement-framework
#2
Kristen Hayward, Alexi Grom, Eyal Muscal, Peter A Nigrovic, Kelly A Rouster-Stevens, Kaveh Ardalan, Linda Hiraki, L Nandini Moorthy
Background: The American College of Rheumatology (ACR)/Childhood Arthritis and Rheumatology Research Alliance (CARRA) Mentoring Interest Group (AMIGO) is an inter-institutional mentorship program launched to target mentorship gaps within pediatric rheumatology. Initial program evaluation indicated increased mentorship access. Given the small size of the pediatric rheumatology workforce, maintaining a consistent supply of mentors was a potential threat to the longevity of the network. Our aims were to: (i) describe the sustainability of AMIGO over the period 2011-2018, (ii) highlight ongoing benefits to participants, and (iii) describe challenges in the maintenance of a mentorship network...
December 12, 2023: Research Square
https://read.qxmd.com/read/37364517/infectious-profiles-in-pediatric-anti-n-methyl-d-aspartate-receptor-encephalitis
#3
JOURNAL ARTICLE
Alexander J Sandweiss, Timothy A Erickson, Yike Jiang, Varun Kannan, Jonathan M Yarimi, Jesse M Levine, Kristen Fisher, Eyal Muscal, Gail Demmler-Harrison, Kristy O Murray, Shannon E Ronca
Anti-N-methyl-d-aspartate receptor autoimmune encephalitis (NMDAR AE) is an antibody-mediated neurological disorder that may be caused by post-herpes simplex virus-1 meningoencephalitis (HSV ME) and ovarian teratomas, although most pediatric cases are idiopathic. We sought to evaluate if other infections precede NMDAR AE by conducting a single-center, retrospective, case-control study of 86 pediatric cases presenting to Texas Children's Hospital between 2006 and 2022. HSV ME (HSV-1 and HSV-2) was a significantly more common preceding infection in the experimental group compared to control patients with idiopathic intracranial hypertension, while there was no difference in remote HSV infection between the two groups...
August 15, 2023: Journal of Neuroimmunology
https://read.qxmd.com/read/37094999/arterial-spin-labeling-changes-parallel-asymmetric-perisylvian-and-perirolandic-symptoms-in-3-pediatric-cases-of-anti-nmdar-encephalitis
#4
JOURNAL ARTICLE
Alexander J Sandweiss, Varun Kannan, Nilesh K Desai, Stephen F Kralik, Eyal Muscal, Kristen S Fisher
BACKGROUND AND OBJECTIVES: Anti-NMDA receptor autoimmune encephalitis (NMDAR AE) is an autoantibody-mediated disorder characterized by seizures, neuropsychiatric symptoms, movement disorder, and focal neurologic deficits. Conventionally defined broadly as an inflammatory brain disease, the heterotopic localization is rarely discussed in children. Imaging findings are often nonspecific, and there are no early biomarkers of disease other than the presence of anti-NMDAR antibodies. METHODS: We conducted a retrospective analysis of our pediatric NMDAR AE cases (as determined by either positive serum or CSF antibodies or both) at Texas Children's Hospital between 2020-2021 and extracted medical record data of those patients who had arterial spin labeling (ASL) as part of their imaging workup for encephalitis...
July 2023: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/36970506/long-term-neuropsychological-outcomes-in-children-with-febrile-infection-related-epilepsy-syndrome-fires-treated-with-anakinra
#5
JOURNAL ARTICLE
Anima Shrestha, E Lynne Wood, Gretchen Berrios-Siervo, Coral M Stredny, Katrina Boyer, Clemente Vega, Srishti Nangia, Eyal Muscal, Krista Eschbach
BACKGROUND: Febrile-infection related epilepsy syndrome (FIRES) is a rare epilepsy syndrome in which a previously healthy individual develops refractory status epilepticus in the setting of a preceding febrile illness. There are limited data regarding detailed long-term outcomes. This study aims to describe the long-term neuropsychological outcomes in a series of pediatric patients with FIRES. METHODS: This is a retrospective multi-center case series of pediatric patients with a diagnosis of FIRES treated acutely with anakinra who had neuropsychological testing at least 12 months after status epilepticus onset...
2023: Frontiers in Neurology
https://read.qxmd.com/read/36908050/variation-in-early-anakinra-use-and-short-term-outcomes-in-multisystem-inflammatory-syndrome-in-children
#6
JOURNAL ARTICLE
Joyce C Chang, Cameron C Young, Eyal Muscal, Sara K Sexson Tejtel, Margaret M Newhams, Suden Kucukak, Hillary Crandall, Aline B Maddux, Courtney M Rowan, Natasha B Halasa, Helen A Harvey, Charlotte V Hobbs, Mark W Hall, Michele Kong, Cassyanne L Aguiar, Jennifer E Schuster, Julie C Fitzgerald, Aalok R Singh, Kari Wellnitz, Ryan A Nofziger, Natalie Z Cvijanovich, Elizabeth H Mack, Adam J Schwarz, Sabrina Heidemann, Jane W Newburger, Laura D Zambrano, Angela P Campbell, Manish M Patel, Adrienne G Randolph, Mary Beth F Son
OBJECTIVE: Evidence regarding effectiveness of interleukin-1 receptor antagonism in Multisystem Inflammatory Syndrome in Children (MIS-C) is lacking. We characterized variation in initial treatment with anakinra and evaluated cardiovascular outcomes associated with adding anakinra to standard initial therapy. METHODS: We conducted a retrospective cohort study of MIS-C cases in a U.S. surveillance registry November 2020-December 2021. Day 0 was the first calendar day of immunomodulatory treatment...
March 12, 2023: Arthritis & Rheumatology
https://read.qxmd.com/read/36740356/neuroinflammation-in-obsessive-compulsive-disorder-sydenham-chorea-pediatric-autoimmune-neuropsychiatric-disorders-associated-with-streptococcal-infections-and-pediatric-acute-onset-neuropsychiatric-syndrome
#7
REVIEW
Allison Vreeland, Margo Thienemann, Madeleine Cunningham, Eyal Muscal, Christopher Pittenger, Jennifer Frankovich
Sydenham chorea (SC), pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS) are postinfectious neuroinflammatory diseases that involve the basal ganglia and have obsessive-compulsive disorder as a major manifestation. As is true for many childhood rheumatological diseases and neuroinflammatory diseases, SC, PANDAS and PANS lack clinically available, rigorous diagnostic biomarkers and randomized clinical trials...
March 2023: Psychiatric Clinics of North America
https://read.qxmd.com/read/36645080/systemic-inflammatory-markers-and-eeg-features-of-children-with-fires-receiving-anakinra
#8
JOURNAL ARTICLE
Yi-Chen Lai, Gabriella Abou-El-Kheir, Thao Nguyen, Margo Hanerhoff, James J Riviello, Eyal Muscal
In a retrospective case series of 10 children with cryptogenic FIRES, we sought to describe the early clinical course and potential biomarkers following anakinra initiation. Six children achieved anesthetic withdrawal within 3 weeks of therapy and one in week four. Of the available cEEG (six children), CRP (10 children), and serum cytokine (six children) studies, there were temporal changes in highly epileptiform bursts (observed in three children), CRP, IL-6, and IL-10 levels that might parallel clinical progression...
January 16, 2023: Annals of Clinical and Translational Neurology
https://read.qxmd.com/read/36367723/postdischarge-glucocorticoid-use-and-clinical-outcomes-of-multisystem-inflammatory-syndrome-in-children
#9
JOURNAL ARTICLE
Mary Beth F Son, Laura Berbert, Cameron Young, Johnathan Dallas, Margaret Newhams, Sabrina Chen, Stacy P Ardoin, Matthew L Basiaga, Susan P Canny, Hillary Crandall, Sanjeev Dhakal, Anita Dhanrajani, Anna Carmela P Sagcal-Gironella, Charlotte V Hobbs, Livie Huie, Karen James, Madelyn Jones, Susan Kim, Geraldina Lionetti, Melissa L Mannion, Eyal Muscal, Sampath Prahalad, Grant S Schulert, Kristen Sexson Tejtel, D Sofia Villacis-Nunez, Eveline Y Wu, Laura D Zambrano, Angela P Campbell, Manish M Patel, Adrienne G Randolph
Importance: Minimal data are available regarding the postdischarge treatment of multisystem inflammatory syndrome in children (MIS-C). Objectives: To evaluate clinical characteristics associated with duration of postdischarge glucocorticoid use and assess postdischarge clinical course, laboratory test result trajectories, and adverse events in a multicenter cohort with MIS-C. Design, Setting, and Participants: This retrospective cohort study included patients with MIS-C hospitalized with severe illness and followed up for 3 months in an ambulatory setting...
November 1, 2022: JAMA Network Open
https://read.qxmd.com/read/35645367/lupus-nephritis-autoantibody-production-and-kidney-outcomes-in-males-with-childhood-onset-systemic-lupus-erythematosus
#10
JOURNAL ARTICLE
Scott E Wenderfer, Alvaro Orjuela, Mir Reza Bekheirnia, Maria Pereira, Eyal Muscal, Michael C Braun, Marietta De Guzman
Childhood-onset systemic lupus erythematosus (cSLE) only represents 20% of all SLE patients, and males with SLE only represent 10%. To study this rare SLE subset, males diagnosed with cSLE over a 30-year period were identified. Organ involvement, autoantibody production, hypocomplementemia, and kidney biopsy findings were compared to cSLE females. Outcomes were assessed using SLE Disease Activity Index scores, Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index, and Childhood Arthritis and Rheumatology Research Alliance definitions for nephritis responsiveness...
May 6, 2022: Pediatric Reports
https://read.qxmd.com/read/35507775/comparison-of-laboratory-and-hemodynamic-time-series-data-across-original-alpha-and-delta-variants-in-patients-with-multisystem-inflammatory-syndrome-in-children
#11
JOURNAL ARTICLE
Parag N Jain, Sebastian Acosta, Ananth Annapragada, Paul A Checchia, Axel Moreira, Eyal Muscal, Sarah E Sartain, S Kristen Sexson Tejtel, Tiphanie P Vogel, Lara Shekerdemian, Craig G Rusin
OBJECTIVES: To compare the clinical, laboratory, and hemodynamic parameters during hospitalization for patients with multisystem inflammatory syndrome in children (MIS-C), across the Original/Alpha and the Delta variants of severe acute respiratory syndrome coronavirus 2 infection. DESIGN: Retrospective cohort study. SETTING: Single-center quaternary children's hospital. PATIENTS: Children with MIS-C admitted from May 2020 to February 2021(Original and Alpha variant cohort) and August 2021 to November 2021 (Delta variant cohort)...
May 4, 2022: Pediatric Critical Care Medicine
https://read.qxmd.com/read/35373880/covid-19-vaccine-mrna-bnt162b2-and-covid-19-infection-induced-thrombotic-thrombocytopenic-purpura-in-adolescents
#12
JOURNAL ARTICLE
Luna Vorster, Susan E Kirk, Eyal Muscal, Jenny M Despotovic, Clay T Cohen, Sarah E Sartain
The mRNA COVID-19 vaccine and COVID-19 infection caused by the SARS-CoV-2 virus may be immunologic triggers for the development of thrombotic thrombocytopenic purpura (TTP). There is not yet literature that discusses TTP induced by COVID-19 vaccination or infection in pediatric or adolescent patients. We describe three adolescents presenting with TTP (both de novo and relapsed disease) following administration of the Pfizer COVID-19 vaccine or after COVID-19 infection. Our observations demonstrate that the Pfizer-BioNTech mRNA vaccine and COVID-19 infection can act as triggers for the development/relapse of both congenital and acquired TTP...
April 4, 2022: Pediatric Blood & Cancer
https://read.qxmd.com/read/35344047/outcomes-after-sars-cov-2-vaccination-among-children-with-a-history-of-multisystem-inflammatory-syndrome
#13
JOURNAL ARTICLE
Matthew Wisniewski, Angela Chun, Stefano Volpi, Eyal Muscal, S Kristen Sexson Tejtel, Flor Munoz, Tiphanie P Vogel
No abstract text is available yet for this article.
March 1, 2022: JAMA Network Open
https://read.qxmd.com/read/34798957/the-role-of-pediatric-rheumatologists-in-autoimmune-brain-disease
#14
REVIEW
Kathryn Taylor, Eyal Muscal, Heather Van Mater
The spectrum of autoimmune and inflammatory brain diseases continues to evolve with medical advances facilitating both the detection of inflammation of the central nervous system and the discovery of novel disease mechanisms. The clinical overlap of these disorders with primary rheumatic diseases and the efficacy of immunotherapy have led to strong partnerships between pediatric rheumatologists, neurologists, psychiatrists, and other providers in the care of children with these conditions. Early diagnosis and initiation of targeted therapy improve clinical outcomes, highlighting the importance of interdisciplinary collaborative care...
February 2022: Rheumatic Diseases Clinics of North America
https://read.qxmd.com/read/34542573/use-and-safety-of-immunotherapeutic-management-of-n-methyl-d-aspartate-receptor-antibody-encephalitis-a-meta-analysis
#15
JOURNAL ARTICLE
Margherita Nosadini, Michael Eyre, Erika Molteni, Terrence Thomas, Sarosh R Irani, Josep Dalmau, Russell C Dale, Ming Lim, Banu Anlar, Thaís Armangue, Susanne Benseler, Tania Cellucci, Kumaran Deiva, William Gallentine, Grace Gombolay, Mark P Gorman, Yael Hacohen, Yuwu Jiang, Byung Chan Lim, Eyal Muscal, Alvin Ndondo, Rinze Neuteboom, Kevin Rostásy, Hiroshi Sakuma, Stefano Sartori, Suvasini Sharma, Silvia Noemi Tenembaum, Heather Ann Van Mater, Elizabeth Wells, Ronny Wickstrom, Anusha K Yeshokumar
Importance: Overall, immunotherapy has been shown to improve outcomes and reduce relapses in individuals with N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis (NMDARE); however, the superiority of specific treatments and combinations remains unclear. Objective: To map the use and safety of immunotherapies in individuals with NMDARE, identify early predictors of poor functional outcome and relapse, evaluate changes in immunotherapy use and disease outcome over the 14 years since first reports of NMDARE, and assess the Anti-NMDAR Encephalitis One-Year Functional Status (NEOS) score...
November 1, 2021: JAMA Neurology
https://read.qxmd.com/read/34461635/ifn-%C3%AE-signature-in-the-plasma-proteome-distinguishes-pediatric-hemophagocytic-lymphohistiocytosis-from-sepsis-and-sirs
#16
JOURNAL ARTICLE
Howard Lin, Brooks P Scull, Baruch R Goldberg, Harshal A Abhyankar, Olive S Eckstein, Daniel J Zinn, Joseph Lubega, Jennifer Agrusa, Nader K El-Mallawanay, Nitya Gulati, Lisa R Forbes, Ivan K Chinn, Rikhia Chakraborty, Jessica Velazquez, Jordana Goldman, Dalia A Bashir, Fong Wilson Lam, Eyal Muscal, Michael M Henry, Jay Greenberg, Stephan Ladisch, Michelle L Hermiston, Lauren K Meyer, Michael Raymond Jeng, Ahmed Naqvi, Kenneth L McClain, Trung Nguyen, Hector R Wong, Tsz-Kwong Man, Michael B Jordan, Carl E Allen
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by pathologic immune activation in which prompt recognition and initiation of immune suppression is essential for survival. Children with HLH have many overlapping clinical features with critically ill children with sepsis and systemic inflammatory response syndrome (SIRS) in whom alternative therapies are indicated. To determine if plasma biomarkers could differentiate HLH from other inflammatory conditions and to better define a 'core inflammatory signature' of HLH, concentrations of inflammatory plasma proteins were compared in 40 patients with HLH to 47 pediatric patients with severe sepsis or SIRS...
August 30, 2021: Blood Advances
https://read.qxmd.com/read/34301820/international-consensus-recommendations-for-the-treatment-of-pediatric-nmdar-antibody-encephalitis
#17
JOURNAL ARTICLE
Margherita Nosadini, Terrence Thomas, Michael Eyre, Banu Anlar, Thais Armangue, Susanne M Benseler, Tania Cellucci, Kumaran Deiva, William Gallentine, Grace Gombolay, Mark P Gorman, Yael Hacohen, Yuwu Jiang, Byung Chan Lim, Eyal Muscal, Alvin Ndondo, Rinze Neuteboom, Kevin Rostásy, Hiroshi Sakuma, Suvasini Sharma, Silvia Noemi Tenembaum, Heather Ann Van Mater, Elizabeth Wells, Ronny Wickstrom, Anusha K Yeshokumar, Sarosh R Irani, Josep Dalmau, Ming Lim, Russell C Dale
OBJECTIVE: To create an international consensus treatment recommendation for pediatric NMDA receptor antibody encephalitis (NMDARE). METHODS: After selection of a panel of 27 experts with representation from all continents, a 2-step Delphi method was adopted to develop consensus on relevant treatment regimens and statements, along with key definitions in pediatric NMDARE (disease severity, failure to improve, and relapse). Finally, an online face-to-face meeting was held to reach consensus (defined as ≥75% agreement)...
July 2021: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/34215388/inflammatory-diseases-of-the-central-nervous-system
#18
REVIEW
Nikita Malani Shukla, Timothy E Lotze, Eyal Muscal
Pediatric neuroinflammatory conditions are a complex group of disorders with a wide range of clinical presentations. Patients can present with a combination of focal neurologic deficits, encephalopathy, seizures, movement disorders, or psychiatric manifestations. There are several ways that pediatric neuroinflammatory conditions can be classified, including clinical presentation, pathophysiologic mechanism, and imaging and laboratory findings. In this article, we group these conditions into acquired demyelinating diseases, immune-mediated epilepsies/encephalopathies, primary rheumatologic conditions with central nervous system (CNS) manifestations, CNS vasculitis, and neurodegenerative/genetic conditions with immune-mediated pathophysiology and discuss epidemiology, pathophysiology, clinical presentation, treatment, and prognosis of each disorder...
August 2021: Neurologic Clinics
https://read.qxmd.com/read/33949910/immune-thrombocytopenia-following-multisystem-inflammatory-syndrome-in-children-mis-c-a-case-series
#19
JOURNAL ARTICLE
Eric Y Kok, Lakshmi Srivaths, Amanda B Grimes, Tiphanie P Vogel, S Kristen Sexson Tejtel, Eyal Muscal
Patients with coronavirus disease 2019 (COVID-19) from novel coronavirus (SARS-CoV-2) infection may present with immune thrombocytopenia (ITP). Multisystem inflammatory syndrome in children (MIS-C) is a serious complication of SARS-CoV-2 causing systemic organ dysfunction. This case series presents the first reported cases of patients who developed ITP following MIS-C, while completing corticosteroid tapers. These patients responded to standard of care therapies for ITP and had appropriate platelet count recovery...
October 2021: Pediatric Hematology and Oncology
https://read.qxmd.com/read/33681649/proposal-to-optimize-evaluation-and-treatment-of-febrile-infection-related-epilepsy-syndrome-fires-a-report-from-fires-workshop
#20
JOURNAL ARTICLE
Sookyong Koh, Elaine Wirrell, Annamaria Vezzani, Rima Nabbout, Eyal Muscal, Marios Kaliakatsos, Ronny Wickström, James J Riviello, Andreas Brunklaus, Eric Payne, Antonio Valentin, Elizabeth Wells, Jessica L Carpenter, Kihyeong Lee, Yi-Chen Lai, Krista Eschbach, Craig A Press, Mark Gorman, Coral M Stredny, William Roche, Tara Mangum
Febrile infection-related epilepsy syndrome (FIRES) is a rare catastrophic epileptic encephalopathy that presents suddenly in otherwise normal children and young adults causing significant neurological disability, chronic epilepsy, and high rates of mortality. To suggest a therapy protocol to improve outcome of FIRES, workshops were held in conjunction with American Epilepsy Society annual meeting between 2017 and 2019. An international group of pediatric epileptologists, pediatric neurointensivists, rheumatologists and basic scientists with interest and expertise in FIRES convened to propose an algorithm for a standardized approach to the diagnosis and treatment of FIRES...
March 2021: Epilepsia Open
keyword
keyword
716
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.